DCGI approval for Sputnik V vaccine expected soon: Dr Reddy’s
Dr Reddy’s Laboratories expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said. “We expect to get approval in…
Dr Reddy’s submits Indian trials data of Sputnik to DCGI
Hyderabad: Dr Reddy’s Laboratories, which has applied for emergency use authorisation (EUA) for Russian C-19 vaccine Sputnik V, has submitted data from the Indian Phase II/III trials as directed by the expert committee that…
DCGI Disapproves Administration Of Covaxin To Those Below 18 Yrs
New Delhi : In a major shift of narrative, the government has now disapproved the authorisation of Bharat Biotech’s Covid vaccine to people below 18 years of age whereas earlier, it…
Bharat Biotech CMD Dr Ella claims Covaxin safest; hails DCGI decision
Claiming that the Covid-19 vaccine, Covaxin, developed and manufactured by Bharat Biotech is safest, Dr Krishna Ella, chairman and managing director of Bharat Biotech, hailed the decision of Indian drug…
Zydus Cadila gets DCGI nod to initiate Phase-3 clinical trials for Covid-19 vaccine
Drug firm Zydus Cadila on Sunday said it has received DCGI approval to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D. The company will now be initiating Phase III clinical trial in…
Covishield Gets Approval From DCGI’s Expert Panel
New Delhi : Covishield, the vaccine candidate from Pune-based Serum Institute of India, was approved by a Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) late…
India will have happy New Year with vaccine in hand: DCGI
The drug regulator is currently analysing the data submitted by Serum Institute of India, which is manufacturing Oxford-AstraZeneca vaccine and Bharat Biotech, which is making indigenous vaccine in collaboration with ICMR. The expert panel…
Glenmark launches drug in India to treat Type 2 diabetes
Glenmark Pharmaceuticals has launched a fixed-dose combination (FDC) of its novel, patent-protected Sodium Glucose Co-Transporter Inhibitor (SGLT2i) – Remogliflozin Etabonate and another widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor) –…
DCGI Directs To Recall Batches Of Rapid Antigen IVD Kits Of Labcare Diagnostics And SD Biosensor
Mumbai : The Drugs Controller General of India (DCGI) has directed all state licensing authorities (SLAs) to recall batches of rapid antigen in vitro diagnostic (IVD) kits of Gujarat-based manufacturer…
DCGI Seeking More Data For Granting Emergency Use Authorisation Won’t Impact Timeline For Vaccine Roll-Out: Govt
New Delhi : The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting that drug…
